Ceiling Prices Of 915 Formulations Fixed: Govt

New Delhi : The government on Tuesday said that till July 17, ceiling prices have been fixed for 915 scheduled formulations. Out of the total, ceiling prices of 691 formulations have been fixed under the National List of Essential Medicines (NLEM) 2022 and 224 formulations under NLEM 2015, Union Minister of State for Chemicals and Fertilisers Bhagwanth Khuba said in a written reply to Rajya Sabha.

Besides, the retail price of around 2,450 new drugs under Drugs (Prices Control) Order, 2013 has been fixed till July 7, 2023, he noted.

The minister also stated that a total of 5,772 complaints alleging overcharging were received by drug pricing regulatory body NPPA over the five-year period ranging between 2018-19 and 2022-23.

Replying to a query regarding the Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs), Khuba said 9,512 outlets are now functional across the country.

The product basket of PMBJP presently comprises about 1,800 medicines and 285 surgical devices, covering all major therapeutic groups, he noted.

The government has fixed a target for opening 10,000 PMBJKs by March 2024.

Related Posts

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…

Chemists strike on May 20: Reasons behind today’s all-India strike

While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures